Evidence map›Paper›PMID 35864522›Full record

ArticleSubstance abuse treatment, prevention, and policy2022

The effects of opioid policy changes on transitions from prescription opioids to heroin, fentanyl and injection drug use: a qualitative analysis.

Julia Dickson-Gomez, Sarah Krechel, Antoinette Spector, Margaret Weeks, Jessica Ohlrich, H Danielle Green Montaque, Jianghong Li

Abstract read
In one paragraph

Article in Substance abuse treatment, prevention, and policy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Fentanyl Research: Key to Fighting the Opioid Crisis.Journal of clinical medicine · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Julia Dickson-GomezInstitute for Health and Equity, Medical College of Wisconsin, Milwaukee, USA. jdickson@mcw.edu.
Sarah KrechelInstitute for Health and Equity, Medical College of Wisconsin, Milwaukee, USA.
Antoinette SpectorDepartment of Rehabilitative Sciences and Technology, University of Wisconsin, Milwaukee, USA.
Margaret WeeksInstitute for Community Research, Hartford, CT, USA.
Jessica OhlrichInstitute for Health and Equity, Medical College of Wisconsin, Milwaukee, USA.
H Danielle Green MontaqueInstitute for Community Research, Hartford, CT, USA.
Jianghong Li

Funding

Effects of State Laws to Reduce Opioid Diversion on Transitions to Injection Drug Use and HIV/HCV TransmissionR01DA044971 · NIDA · MEDICAL COLLEGE OF WISCONSIN · PI DICKSON-GOMEZ, JULIA B · 2018 to 2022
$3.0M
NIDA NIH HHS R01 DA044971
6 · The paper itself

Abstract

backgroundBeginning in the 1990s, nonmedical use of prescription opioids (POs) became a major public health crisis. In response to rising rates of opioid dependence and fatal poisonings, measures were instituted to decrease the prescription, diversion, and nonmedical use of POs including prescription drug monitoring programs (PDMPs), pain clinic laws, prescription duration limits, disciplining doctors who prescribed an excessive number of POs, and the advent of abuse deterrent formulations of POs. This paper explores the unintended effects of these policies in the descriptions of why people who use opioids transitioned from PO to injection or heroin/fentanyl use.

methodsWe conducted 148 in-depth-interviews with people who use prescription opioids nonmedically, fentanyl or heroin from a rural, urban and suburban area in three states, Connecticut, Kentucky and Wisconsin. Interviews with people who use opioids (PWUO) focused on how they initiated their opioid use and any transitions they made from PO use to heroin, fentanyl or injection drug use.

resultsThe majority of participants reported initiating use with POs, which they used for medical or nonmedical purposes. They described needing to take more POs or switched to heroin or fentanyl as their tolerance increased. As more policies were passed to limit opioid prescribing, participants noticed that doctors were less likely to prescribe or refill POs. This led to scarcity of POs on the street which accelerated the switch to heroin or fentanyl. These transitions likely increased risk of overdose and HIV/HCV infection.

conclusionsA careful analysis of how and why people say they transitioned from PO to heroin or fentanyl reveals many unintended harms of policy changes to prevent overprescribing and diversion. Results highlight the importance of mitigating harms that resulted from policy changes.

Indexed as

Drug OverdoseOpioid-Related DisordersAnalgesics, OpioidFentanylHeroinHumansPolicyPractice Patterns, Physicians'PrescriptionsAnalgesics, OpioidFentanylHeroinFentanylHeroinOpioid prescribing guidelinesOpioidsPrescription drug monitoring program (PDMP)Prescription opioids

Identifiers

PMID35864522
PMCPMC9306091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.